Lowering cholesterol and 10 other ways to cut your dementia risk
Dementia currently has no cure. But while there is no guaranteed way to prevent it, there are several lifestyle choices that could potentially contribute to protecting against including lowering cholesterol.
New research has found that people who have low levels of "bad" cholesterol in their blood could reduce the risk of dementia by 26%.
People with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood have a lower overall risk of dementia, and a reduced risk of Alzheimer's disease specifically, according to research published in the Journal of Neurology Neurosurgery and Psychiatry.
Taking statins also provided an "additional protective effect" against the condition for those people with low levels of bad cholesterol, researchers found.
Commenting on the study, Dr Julia Dudley, head of research at Alzheimer's Research UK, said: "This large study looked at patient records for levels of LDL cholesterol and the risk of dementia, it also examined those patients who were on statins.
"It found that those people with lower LDL levels had a reduced risk of dementia. The use of statins seemed to offer a protective effect – even in those who already had cholesterol levels within a lower range."
However, Dr Dudley says dementia risk is complex and influenced by many factors. "Without a detailed picture of what's going on in the brain, we do not know if there is a direct link between lower cholesterol and reduced dementia risk. Clinical trials will be key to understanding what effects statins might be having on disease processes in the brain."
In the meantime, she says keeping hearts healthy remains one of the most effective ways we can protect our brain health.
"If you have any concerns about your cholesterol levels, you should speak to your GP," she adds.
Dementia affects nearly one million people in the UK, with the latest projections estimating that this number could rise to 1.4 million by 2040 and cholesterol isn't the only risk factor.
A study from 2020 found 12 risk factors that could lead to a dementia diagnosis, including obesity, smoking, depression, lack of physical activity, low level of education, high blood pressure, diabetes, excessive drinking, hearing problems, traumatic brain injury, air pollution, and social isolation.
But a further, more recent report, published in The Lancet journal, has added vision loss and high cholesterol to this list.
The researchers said that the potential for prevention is high, in that some of these conditions can be prevented or reversed.
"Nearly half of dementias could theoretically be prevented by eliminating these 14 risk factors," the study said.
In fact, the authors estimated that 45% of our risk of the disease can be changed by preventing or reversing these conditions.
"It's never too early or too late to take action," lead author Prof Gill Livingston, from University College London, told the BBC.
'Governments must reduce risk inequalities by making healthy lifestyles as achievable as possible for everyone.'
The researchers also provided a recommendations list for healthcare systems to use when looking to reduce the likelihood of dementia. This includes:
Ensuring hearing aids are accessible
Investing in good quality education
Emphasis on exercise and sports
Encourage people to stop smoking
Treating high blood pressure
Preventing obesity
Reducing problem drinking
Eyesight screening
Air pollution reduction
Ensuring people are not isolated or lonely
While there are some factors on the list that may be out of your control, such as hearing loss, a traumatic brain injury, and poor eyesight, there are others where you can take action in order to prevent the likelihood of dementia.
If you suffer from, or are affected by, social isolation, excessive drinking, smoking, obesity, depression, physical inactivity, high blood pressure, or high cholesterol, many of these are modifiable lifestyle factors that you can speak to your GP or a qualified healthcare professional about.
There are also organisations that offer support for some of the conditions stated, such as mental health charity Mind, Alcohol Change, or the NHS Smokefree National Helpline on 0300 123 1044.
Read more about dementia:
Making tea and meeting up with friends could keep dementia patients independent for longer (Yahoo Life UK, 4-min read)
Two-thirds of people with dementia are women. Experts now think they might know why (HuffPost, 2-min read)
The love of my life was diagnosed with dementia at 48 (Yahoo Life UK, 9-min read)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fast Company
2 hours ago
- Fast Company
Enough hype about AI in health—let's talk about results
There's no shortage of big promises about AI in healthcare. The U.S. government announced a $500 billion Stargate initiative to fund AI infrastructure, while the UK government announced £82.6 million in research funding for three projects, two of which are using AI to tackle cancer and Alzheimer's disease. But ask any patient waiting for a diagnosis, or a clinician searching for certainty, and the real question cuts through all the noise: When will all the innovation deliver real impact where it matters most? We've entered an era where healthcare data is measured in exabytes—genomes, images, clinical notes, labs, and signals from every continent. At SOPHiA GENETICS, we've just achieved the milestone of analyzing 2 million patient profiles. It's a number that was unimaginable a decade ago. Yet the value of data isn't in volume. It's what you do with it. Insight matters only if it changes an outcome, shortens a diagnostic odyssey, or opens up a new chance for a patient. It's time to move from conversation to action. Too often, insights get trapped in institutional silos or left in endless pilot projects, just out of reach of the people who need them. 3 ways AI is already transforming medicine Today, technology can connect, for example, a patient in São Paulo with expertise in Seoul, uncovering patterns invisible to the human eye. Here are several ways AI is helping now. 1. Improving diagnostic accuracy: AI algorithms, particularly those based on deep learning, have demonstrated remarkable accuracy in diagnosing diseases from medical images and test results. These systems are trained on vast datasets, allowing them to recognize patterns and anomalies that might be missed by the human eye. For example, in dermatology, AI systems trained on images of skin lesions have shown the ability to detect skin cancers, such as melanoma, with high levels of precision. 2. Enhancing cancer prevention: AI techniques can be used to screen individuals for genomic markers and develop personalized cancer risk prediction scores. This proactive approach can help screen younger patients for genomic predispositions, empowering them to make informed prevention decisions and proactively monitor their health. 3. Tailoring treatments to genomic profiles: One of the most significant applications of AI is in the field of genomics. AI can analyze vast genomic datasets to identify mutations and variations that might influence an individual's response to certain treatments. For example, our SOPHiA DDM product can identify specific genomic markers that are susceptible to targeted cancer therapies, increasing the efficacy of the treatment and minimizing the risk of adverse reactions, for a more effective and safer treatment plan for patients. To scale up these AI applications there are many regulatory and compliance barriers to overcome. This requires investment in data security, creating clear guidelines, data security measures, and ensuring clinicians are fully trained. Our goal should be to create a regulatory environment that fosters innovation while safeguarding patient data and promoting public trust. We must democratize this powerful data to enable more physicians, practices, and hospitals to incorporate AI into daily clinical use so that a greater number of patients can access data-driven medicine, not just a select few. My message for governments investing in AI is clear: Balance investing in future AI tools with validating existing solutions that have already been proven to improve patient outcomes. Build the bridges that turn breakthroughs into benefits, so that data-driven medicine becomes a reality for every patient.
Yahoo
3 hours ago
- Yahoo
Illinois becomes first state to require that all insurance covers Alzheimer's treatment
SPRINGFIELD, Ill. (WCIA) — Illinois is making a major expansion in patient care and access to new treatment for Alzheimer's, thanks to a new state law taking effect in July 2025. Gov. J.B. Pritzker signed a bill that will require state health insurance to cover U.S. Food and Drug Administration (FDA) approved medicine to slow down Alzheimer's and other related diseases. SEE ALSO: New Illinois laws and tax changes set to kick in on July 1, 2025 Some Alzheimer's patients will no longer have to go through step therapy — a process where insurers require patients to try and test less expensive drugs before covering the actual medication prescribed by their doctor. The Alzheimer's Association Illinois Chapter, which has been a forefront advocate for this, called the law 'groundbreaking.' 'For people living with Alzheimer's, slowing the progression of the disease changes someone's life — not only that individual's life, but the lives of their caregivers and all those around them, family and friends,' said David Olson, Director of State Affairs at the Alzheimer's Association Illinois Chapter. This coverage will also include diagnostic testing at the doctor's request. This ensures patients can access an accurate diagnosis before even starting the treatment. In 2020, there were 230,000 seniors with Alzheimer's disease or a related dementia in the state, and according to the Illinois Department of Health, that number is expected to increase to 260,000 this year. With the rise in medical costs, insurance coverage is essential for most families. Bill creating Office of State Public Defender heads to Pritzker's desk The bill's sponsor in the House, Rep. Mary Gill (D-Chicago), said with dementia, time is always at the essence. 'When it comes to slowing Alzheimer's and other dementias, every moment counts,' Gill said. 'We can't waste time on insurance gimmicks like step therapy to save a few bucks, which is why I'm thankful for the strong advocacy and bipartisan support this legislation received.' Other private insurance plans will also begin covering FDA-approved treatment starting in 2027. 'We worked collaboratively with the insurance industry on this legislation,' Olson said. 'We were able to find and agree upon language here that expands access in a way that also isn't increasing cost to consumers.' Currently, there are two types of treatments for Alzheimer's approved by the FDA. One is Lecanemab, and the other is Donanemab. These will not end the disease, as there is currently no cure for Alzheimer's. This law makes Illinois the first state to require such treatment, and advocates said they hope other states will follow its lead. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Los Angeles Times
3 hours ago
- Los Angeles Times
How Sleep Disorders Disrupt Brain Health—and Why It Matters
Sleep is more than a nightly recharge—it's a biological necessity that actively maintains and protects the brain. A sleep disorder is an umbrella term for conditions that disrupt normal sleep patterns, affecting both the quality and quantity of sleep. Yet millions suffer from sleep disorders and don't know the long term effects these conditions can have on their brain health. Sleep disorders are conditions that disrupt normal sleep patterns and can lead to excessive daytime sleepiness which is a key symptom of many sleep disorders and can impact daily functioning. Sleep wake disorders broadly categorize conditions that affect both sleep and wakefulness, highlighting the spectrum of disturbances that can occur. Common sleep disorders include insomnia, sleep apnea and restless legs syndrome. From brain structure changes to increased risk of neurological disease, science is finding out just how important sleep is for a healthy mind. Here's what happens when sleep fails and why the brain may pay the price. Sleep isn't just a passive state; it plays a crucial role in keeping brain anatomy intact. A 2023 Mendelian randomization study found a direct causal link between shorter sleep duration and thinner cortex especially in areas that govern memory, cognition and mood regulation [1]. So poor sleep doesn't just correlate with brain issues—it may actually reshape the brain over time. More imaging studies support this. People with neuropsychiatric sleep disorders show noticeable changes in the cortex and brainstem, so disrupted sleep may be a symptom of or a contributor to brain degeneration [11] [12]. According to the International Classification of Sleep Disorders (ICSD) the main types of sleep disorders are insomnia, sleep disordered breathing, hypersomnolence, circadian rhythm disorders, parasomnias and sleep related movement disorders. Many sleep disorders are diagnosed by a combination of clinical history, physical examination and sleep studies such as polysomnography. This duality raises a important clinical question: are we treating sleep disorders as the root cause or just a side effect especially since many sleep disorders can present with overlapping symptoms making diagnosis and treatment complex? One of the brain's housekeeping tasks—clearing out metabolic waste—is done during sleep. Specifically the glymphatic system flushes out neurotoxins like beta-amyloid a protein that builds up in Alzheimer's disease. When sleep is disrupted this cleaning mechanism fails. Poor sleep quality and chronic sleep problems can impede the brain's ability to clear out neurotoxins and increase the risk of cognitive decline [7]. In 2024 the American Heart Association released a statement linking sleep disturbances to increased risk of stroke, Alzheimer's and cognitive decline [2]. Chronic sleep deprivation can also affect day to day brain function. Sleep disturbance is a common feature in many neurodegenerative diseases and can accelerate cognitive impairment. A 2022 study found that long term sleep disruption impairs memory, slows learning and hinders decision making—cognitive functions we take for granted until they start to fade [4]. Sleep deprivation doesn't just make you tired. It changes brain chemistry. A 2020 review found that inadequate sleep affects neurotransmitter balance, weakens synaptic plasticity (the brain's ability to adapt) and even interrupts its natural repair mechanisms—all of which contribute to conditions like Parkinson's and Alzheimer's disease [3]. Common risk factors for sleep deprivation include shift work, chronic illness and certain lifestyle habits which can increase susceptibility to sleep related problems. A broader 2021 synthesis explained that sleep is the cornerstone for immune function, energy balance and synaptic homeostasis—the delicate balance needed for clear thinking and emotional regulation [5]. Once this balance is disrupted neurological decline often follows. Sleep deprivation is both a risk factor for and a consequence of many mental disorders such as insomnia, restless legs syndrome and narcolepsy. It's a vicious cycle: neurological disease disrupts sleep and poor sleep accelerates neurological decline. Sleep deprivation affects both physical and mental health and increases vulnerability to neurological and psychiatric conditions. What happens in the gut doesn't stay in the gut—it can affect your sleep too. Scientists are increasingly looking into the gut brain axis—a complex communication network between the gastrointestinal system and the central nervous system. Recent research suggests that the gut microbiota can influence circadian rhythm and disruptions in this system may contribute to circadian rhythm disorders [12]. A 2022 review found that changes in gut microbiota can influence sleep patterns by altering immune responses, hormonal signals and neural activity [6]. Disruptions in circadian rhythm sleep can lead to various sleep disorders and overall health. These findings open up new possibilities for using diet, probiotics or microbiome-modulating therapies to improve sleep and in turn brain health. For more on this topic Johns Hopkins Medicine has a great primer on gut brain communication. We all know how stress affects sleep. But chronic stress does more than just keep us up at night—it triggers a cascade of inflammatory responses in the brain. Common insomnia symptoms include difficulty falling asleep, staying asleep and early morning awakenings. A 2025 review found that stress related sleep disturbances activate brain immune cells such as astrocytes and microglia. Once triggered these cells can promote neuroinflammation, damage neurons and contribute to conditions like depression and dementia [8]. These findings mirror ongoing research into how trauma, insomnia and mood disorders often share biological pathways tied to inflammation. Chronic insomnia disorder is characterized by persistent sleep difficulties lasting at least three months and often requires targeted treatment. Treating insomnia may involve behavioral, psychological and pharmacological interventions to reduce neuroinflammation and improve sleep quality. Another interesting aspect of the sleep brain relationship is genetic overlap. Many neuropsychiatric disorders share common heritable traits which not only predispose individuals to certain brain conditions but also affect how their brains age [11]. A 2019 Nature Neuroscience study found genetic patterns linking brain disorders and accelerated brain aging [9]. Meanwhile a 2022 study connected poor sleep—especially from conditions like sleep apnea—with vascular cognitive impairment. This research highlighted the impact of chronic oxygen deprivation on small vessels in the brain, a contributor to both stroke and dementia. Sleep studies such as polysomnography and home sleep apnea testing are used to diagnose sleep disorders and assess their impact on brain health [10]. These findings suggest that sleep is not just a lifestyle factor but a deeply intertwined part of our neurological makeup. For more reading Sleep Foundation has a great overview of how genetics and sleep intersect. Keeping a sleep diary can help track sleep patterns and identify potential sleep disorders for further evaluation. Sleep may seem like downtime but for the brain it's maintenance time, repair time and regulation time. Whether it's maintaining brain structure, supporting cognition or taming inflammation, restful sleep is key to long term neurological health. As we learn more about sleep disorders, we should prioritize sleep as a public health issue—not just to feel rested but to preserve ourselves. [1] Gao, X., Wei, T., Xu, S., Sun, W., Zhang, B., Li, C., Sui, R., Fei, N., Li, Y., Xu, W., & Han, D. (2023). Sleep disorders causally affect the brain cortical structure: A Mendelian randomization study. Sleep medicine, 110, 243–253. [2] Gottesman, R. F., Lutsey, P. L., Benveniste, H., Brown, D. L., Full, K. M., Lee, J. M., Osorio, R. S., Pase, M. P., Redeker, N. S., Redline, S., Spira, A. P., & American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; and Council on Hypertension (2024). Impact of Sleep Disorders and Disturbed Sleep on Brain Health: A Scientific Statement From the American Heart Association. Stroke, 55(3), e61–e76. [3] Bishir, M., Bhat, A., Essa, M. M., Ekpo, O., Ihunwo, A. O., Veeraraghavan, V. P., Mohan, S. K., Mahalakshmi, A. M., Ray, B., Tuladhar, S., Chang, S., Chidambaram, S. B., Sakharkar, M. K., Guillemin, G. J., Qoronfleh, M. W., & Ojcius, D. M. (2020). Sleep Deprivation and Neurological Disorders. BioMed research international, 2020, 5764017. [4] Zamore, Z., & Veasey, S. C. (2022). Neural consequences of chronic sleep disruption. Trends in neurosciences, 45(9), 678–691. [5] Lewis L. D. (2021). The interconnected causes and consequences of sleep in the brain. Science (New York, N.Y.), 374(6567), 564–568. [6] Wang, Z., Wang, Z., Lu, T., Chen, W., Yan, W., Yuan, K., Shi, L., Liu, X., Zhou, X., Shi, J., Vitiello, M. V., Han, Y., & Lu, L. (2022). The microbiota-gut-brain axis in sleep disorders. Sleep medicine reviews, 65, 101691. [7] Cieza, A., Anczewska, M., Ayuso-Mateos, J. L., Baker, M., Bickenbach, J., Chatterji, S., Hartley, S., Leonardi, M., Pitkänen, T., & PARADISE Consortium (2015). Understanding the Impact of Brain Disorders: Towards a 'Horizontal Epidemiology' of Psychosocial Difficulties and Their Determinants. PloS one, 10(9), e0136271. [8] Rábago-Monzón, Á. R., Osuna-Ramos, J. F., Armienta-Rojas, D. A., Camberos-Barraza, J., Camacho-Zamora, A., Magaña-Gómez, J. A., & De la Herrán-Arita, A. K. (2025). Stress-Induced Sleep Dysregulation: The Roles of Astrocytes and Microglia in Neurodegenerative and Psychiatric Disorders. Biomedicines, 13(5), 1121. [9] Kaufmann, T., van der Meer, D., Doan, N. T., Schwarz, E., Lund, M. J., Agartz, I., Alnæs, D., Barch, D. M., Baur-Streubel, R., Bertolino, A., Bettella, F., Beyer, M. K., Bøen, E., Borgwardt, S., Brandt, C. L., Buitelaar, J., Celius, E. G., Cervenka, S., Conzelmann, A., Córdova-Palomera, A., … Westlye, L. T. (2019). Common brain disorders are associated with heritable patterns of apparent aging of the brain. Nature neuroscience, 22(10), 1617–1623. [10] Gu, F., Chauhan, V., & Chauhan, A. (2015). Glutathione redox imbalance in brain disorders. Current opinion in clinical nutrition and metabolic care, 18(1), 89–95. [11] Radonjić, N. V., Hess, J. L., Rovira, P., Andreassen, O., Buitelaar, J. K., Ching, C. R. K., Franke, B., Hoogman, M., Jahanshad, N., McDonald, C., Schmaal, L., Sisodiya, S. M., Stein, D. J., van den Heuvel, O. A., van Erp, T. G. M., van Rooij, D., Veltman, D. J., Thompson, P., & Faraone, S. V. (2021). Structural brain imaging studies offer clues about the effects of the shared genetic etiology among neuropsychiatric disorders. Molecular psychiatry, 26(6), 2101–2110. [12] Elvsåshagen, T., Bahrami, S., van der Meer, D., Agartz, I., Alnæs, D., Barch, D. M., Baur-Streubel, R., Bertolino, A., Beyer, M. K., Blasi, G., Borgwardt, S., Boye, B., Buitelaar, J., Bøen, E., Celius, E. G., Cervenka, S., Conzelmann, A., Coynel, D., Di Carlo, P., Djurovic, S., … Kaufmann, T. (2020). The genetic architecture of human brainstem structures and their involvement in common brain disorders. Nature communications, 11(1), 4016.
